Read + Share
Mehra T, Lupatsch JE, Kossler T, Dedes K, et al. Olaparib not cost-effective as maintenance therapy for platinum-sensitive,
BRCA1/2 germline-mutated metastatic pancreatic cancer. PLoS One 2024;19:e0301271.
PMID: 38573891
|
 |
|
Mehra T, Lupatsch JE, Kossler T, Dedes K, et al. Olaparib not cost-effective as maintenance therapy for platinum-sensitive,
BRCA1/2 germline-mutated metastatic pancreatic cancer. PLoS One 2024;19:e0301271.
PMID: 38573891
|
|
|
|